Literature DB >> 11733463

Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis.

M Monzón1, C Oteiza, J Leiva, B Amorena.   

Abstract

The in vitro effect of nine antibiotic combinations was investigated in Staphylococcus epidermidis biofilms using ATP-bioluminescence for viable bacterial cell quantification. Four slime-producing (SP) strains were used to form biofilms 6, 24 and 48 h old. These biofilms were exposed for 24 h to antibiotics at 4 x, 2 x, 1 x and 0.5 x MIC. Combinations involving tetracycline together with another antibiotic were the most efficient at the biofilm age and concentration range under study. The combination vancomycin-rifampicin produced the highest bactericidal effect on 6 h biofilms at 4 x MIC, but this effect decreased dramatically in older biofilms. To detect possible antibiotic synergy in combinations that had a significant killing effect, antibiotics were studied not only in combination but also individually. Synergic effects were observed in all the combinations tested. Differences between the effect in combination and the sum of individual antibiotic effects (degree of synergy) were significant (mostly P< 0.001) and exceeded 1 log10 cfu/mL in the majority of cases. In 48 h biofilms, antibiotics caused a significant bactericidal effect when applied in combination, but never when used individually. These results indicate that the biofilm test applied allows the detection of synergy between antibiotics and suggests that this assay could be useful in clinical and extensive synergy studies on S. epidermidis biofilms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733463     DOI: 10.1093/jac/48.6.793

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  26 in total

1.  Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria.

Authors:  L Cernohorská; M Votava
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

2.  The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance.

Authors:  Julie Liao; Karin Sauer
Journal:  J Bacteriol       Date:  2012-06-22       Impact factor: 3.490

3.  Antimicrobial tolerance of Pseudomonas aeruginosa biofilms is activated during an early developmental stage and requires the two-component hybrid SagS.

Authors:  Kajal Gupta; Cláudia N H Marques; Olga E Petrova; Karin Sauer
Journal:  J Bacteriol       Date:  2013-08-30       Impact factor: 3.490

4.  Elevated levels of the second messenger c-di-GMP contribute to antimicrobial resistance of Pseudomonas aeruginosa.

Authors:  Kajal Gupta; Julie Liao; Olga E Petrova; K E Cherny; Karin Sauer
Journal:  Mol Microbiol       Date:  2014-04-09       Impact factor: 3.501

5.  Osmotic Compounds Enhance Antibiotic Efficacy against Acinetobacter baumannii Biofilm Communities.

Authors:  Azeza Falghoush; Haluk Beyenal; Thomas E Besser; Anders Omsland; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

6.  The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms.

Authors:  Julie Liao; Michael J Schurr; Karin Sauer
Journal:  J Bacteriol       Date:  2013-05-17       Impact factor: 3.490

7.  Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery.

Authors:  Steven M Kwasny; Timothy J Opperman
Journal:  Curr Protoc Pharmacol       Date:  2010-09

8.  Low-molecular weight chitosan enhances antibacterial effect of antibiotics and permeabilizes cytoplasmic membrane of Staphylococcus epidermidis biofilm cells.

Authors:  Petra Kašparová; Martin Zmuda; Eva Vaňková; Olga Maťátková; Jan Masák
Journal:  Folia Microbiol (Praha)       Date:  2021-07-21       Impact factor: 2.099

9.  Development of a standard test to assess the resistance of Staphylococcus aureus biofilm cells to disinfectants.

Authors:  Suzanne B I Luppens; Martine W Reij; Rob W L van der Heijden; Frank M Rombouts; Tjakko Abee
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

10.  Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations.

Authors:  A J Bradley; M J Green
Journal:  J Dairy Sci       Date:  2009-05       Impact factor: 4.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.